Your Article Summary
See Latest ArticlesOA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed
Osteoarthritis and Cartilage , 07/01/09
Graverand-Gastineau MPHL et al. - The development of symptom modifying OA drug is exploding with a plethora of pain pathways being pursued and multiple candidates in advanced stages of clinical development. Structure modification in OA remains complex with significant development challenges.
Related Articles
There Is Inadequate Evidence to Determine the Effectiveness of Nonpharmacological and Nonsurgical Interventions for Hand Osteoarthritis: An Overview of High-Quality Systematic Reviews
Physical Therapy, 11/10/09
Relevance Score: 90%
The Safety of Flavocoxid, a Medical Food, in the Dietary Management of Knee Osteoarthritis
Journal of Medicinal Food, 10/30/09
Relevance Score: 89%
Discriminant Validity of the Western Ontario and McMaster Universities Osteoarthritis Index Physical Functioning Subscale in Community Samples With Hip Osteoarthritis
Archives of Physical Medicine and Rehabilitation, 10/22/09
Relevance Score: 89%
Clinical efficacy evaluation on electroacupuncture for osteoarthritis and observation on biomechanical indexes
Journal of Acupuncture and Tuina Science, 10/19/09
Relevance Score: 89%
Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial
Modern Rheumatology, 10/12/09
Relevance Score: 89%
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures
Osteoporosis International, 12/15/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09